Compliant change workflows, remediation initiatives, and deviation resolution under FDA regulatory scrutiny. We match consultants to FDA Form 483 observation responses, warning letter remediation, pre-inspection cleanup, and consent decree support.
Help assessing observations and preparing responses within the agency timeline.
Remediation plans and execution against commitments made to the agency.
Mock inspections, documentation review, and cleanup ahead of the inspection window.
Compliant change workflows and deviation closure during remediation.
Support for organizations operating under consent decree oversight.
A pharmaceutical organization under FDA warning letter needs a compliance lead, a quality systems consultant, and a CSV specialist to support remediation commitments within the agency's required timeline.
A biotech preparing for its first FDA pre-approval inspection needs contract compliance and CSV support, including mock inspections, documentation review, and validated systems and electronic records that meet Part 11 and Annex 11 requirements before the inspection window.
A growing CDMO adding pharmaceutical clients needs a contract Quality Systems Manager with multi-client GMP experience and validated systems knowledge to build out compliance infrastructure across programs.
A remediation or readiness program with milestones tied to your regulatory commitments and inspection dates.
A compliance lead, quality systems consultant, or CSV specialist embedded in your team to support remediation commitments.
Tell us about the need, its regulatory context, and your systems environment. We will scope the engagement accordingly.